Economic Model Shows That Guideline Recommended Testing of Patients with Early Symptoms of Myeloma Results in Improved Patient Outcomes and Decreased Hospital Costs

被引:0
|
作者
Wu, Elizabeth
Jensen, Ivar S.
Cyr, Philip
Kisner, Harold
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4698
引用
收藏
页数:3
相关论文
共 7 条
  • [1] COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma
    Ramasamy, Karthik
    Sadler, Ross
    Jeans, Sally
    Varghese, Sherin
    Turner, Alison
    Larham, Jemma
    Gray, Nathanael
    Barrett, Joe
    Bowcock, Stella
    Cook, Gordon
    Kyriakou, Chara
    Smith, Dean
    Drayson, Mark
    Basu, Supratik
    Moore, Sally
    McDonald, Sarah
    Gooding, Sarah
    Javaid, Muhammad K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (01) : 95 - 98
  • [2] Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database
    Hummel, James P.
    Leipold, Robert J.
    Amorosi, Stacey L.
    Bao, Haikun
    Deger, Kristen A.
    Jones, Paul W.
    Kansal, Anuraag R.
    Ott, Lesli S.
    Stern, Sean
    Stein, Kenneth
    Curtis, Jeptha P.
    Akar, Joseph G.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2019, 30 (07) : 1066 - 1077
  • [3] EARLY RESULTS: IMPACT OF 4R (RIGHT INFO/CARE/PATIENT/TIME) CARE SEQUENCE PLANS, PROVIDED TO PATIENTS BY ONCOLOGY NURSES, ON TIMING AND SEQUENCE OF GUIDELINE RECOMMENDED CARE
    Bazan, Janeen
    Cleveland, Kim
    Baer, Rachel
    Boecher, Stephanie
    Trosman, Julia
    Trosman, Julia
    Weldon, Christine
    Weldon, Christine
    ONCOLOGY NURSING FORUM, 2021, 48 (02) : 100 - 101
  • [4] EARLY DECISION TO TRANSPORT SEVERELY ILL CARDIAC PATIENTS IS ASSOCIATED WITH IMPROVED OUTCOMES AND LOWER ACCEPTING HOSPITAL COSTS - 8-YEAR EXPERIENCE OF AN ACUTE MYOCARDIAL INTERVENTION TRANSPORT PROGRAM
    SHOOK, TL
    SUN, GW
    BURSTEIN, S
    EISENHAUER, AC
    MATTHEWS, RV
    CIRCULATION, 1995, 92 (08) : 225 - 225
  • [5] ORITAVANCIN IS ASSOCIATED WITH IMPROVED ECONOMIC OUTCOMES VERSUS DALBAVANCE IN PATIENTS WITH ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS TREATED IN A HOSPITAL OPAT SETTING: RESULTS FROM AN OBSERVATIONAL DATABASE
    Fan, W.
    Armstrong, S.
    Plent, S.
    VALUE IN HEALTH, 2016, 19 (03) : A215 - A215
  • [6] Systematic investment in the delivery of guideline-coherent therapy reduces mortality and overall costs in patients with ST-elevation myocardial infarction: Results from the Stent for Life economic model for Romania, Portugal, Basque Country and Kemerovo region
    Wein, Bastian
    Bashkireva, Anna
    Au-Yeung, Alex
    Yoculan, Adam
    Vinereanu, Dragos
    Deleanu, Dan
    Pereira, Helder
    Pereira, Ernesto
    de Mello, Sofia
    Rumoroso, Jose R.
    Ganyukov, Vladimir
    Wijns, William
    Naber, Christoph K.
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2020, 9 (08) : 902 - 910
  • [7] The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer
    Garrison, Louis P., Jr.
    Babigumira, Joseph B.
    Masaquel, Anthony
    Wang, Bruce C. M.
    Lalla, Deepa
    Brammer, Melissa
    VALUE IN HEALTH, 2015, 18 (04) : 541 - 546